Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. - Wikidata - awgldk - TriplyDB

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

http://www.wikidata.org/entity/Q46731864

about

Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications Metformin and body weight Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Lifestyle changes in women with polycystic ovary syndrome Lifestyle changes in women with polycystic ovary syndrome Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Should obese women with polycystic ovary syndrome receive treatment for infertility?Poly Cystic Ovarian Syndrome: An Updated Overview Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline Optimal management of subfertility in polycystic ovary syndrome.Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.PCOS.Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.The impact of female obesity on the outcome of fertility treatment The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro.Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.Assessing and treating insulin resistance in women with polycystic ovarian syndrome Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls Longterm management of Polycystic Ovarian Syndrome (PCOS)Polycystic ovary syndrome (PCOS): metformin A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells.Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment Polycystic ovary syndrome: chemical pharmacotherapy.Managing anovulatory infertility and polycystic ovary syndrome Medical management of metabolic dysfunction in PCOS.Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial.Cardiometabolic aspects of the polycystic ovary syndrome.Evidence for statin therapy in polycystic ovary syndrome.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Role of metformin in the management of polycystic ovary syndrome.Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.

P2860

Q22242884-12EA52D7-B27A-4876-AA46-3D5F15418A2B Q22250988-6EEBE976-DE20-40BD-949F-53B1E4BD7778 Q24197673-E18560D2-3DB1-4E43-9031-BE5181BBA02E Q24234000-060F2D17-0FB2-4398-A650-F4A85C0534D9 Q24235398-59682851-991A-4620-80AF-6B6E96D5BDA4 Q24240654-D586DDCB-249C-4F97-9CEE-AEA1D2C512A9 Q24541340-A717D88C-FBE2-43DD-ADD2-E8348A69456C Q26752564-6DE54BCB-6C9C-4423-B3AE-00026C890CAB Q27002469-1B8B4E08-2441-484A-B7A2-0CD667CF4C18 Q28088433-29977AEB-BA3B-4DA9-954D-B8E4AB2FBF6B Q30847984-CBE5D53F-2544-4A8B-829F-0CE6D593D8AA Q33587839-9B3481ED-E453-469E-A4AA-B3081C370179 Q33587845-FC26E680-16D7-4ED9-AB9D-63154872B664 Q33779073-397CED13-486C-4D2B-A609-5CD06A7C304E Q33988450-7B309200-98B3-46AD-BF2B-856E1A205484 Q34008460-5B884D6E-790A-4D33-9484-30C3FC628D10 Q34010581-B6D747C7-BEFE-4AFC-BB3B-6ABF862CD6C6 Q34011105-0151F345-A703-4213-AC85-2BA3536E11F1 Q34113280-616E8C8E-916D-40B1-B54B-B84BDAD1BE4D Q34157761-FEE37A0D-5E36-483F-A66D-BA27D240DF8C Q34181502-A735207F-855A-4F22-B588-D5465575E945 Q34192281-D532DC6C-51CB-4EA2-8DAA-F35ABBACDD75 Q34450611-9D2B5B55-1F72-40A3-B458-AD4292F87F4C Q34490723-B813AA6A-FCAE-4D87-8875-DC2B58D24938 Q34777753-1C617A55-EA8C-4DD9-823F-3D6B2599DCF2 Q34878055-8B315872-2F98-42B2-B376-8888A90D9471 Q35028637-2D992996-1F6B-4DBB-B877-465703ADBE84 Q35200094-9D911770-1697-4EE0-BBC7-EF311CA7C884 Q35222108-79908F36-765A-48A7-86C9-814087C8065A Q35424614-557315E8-AC66-4518-9667-E6789D4DC2E5 Q35497969-9F8B9FBB-A518-4AC3-903D-B9901856F262 Q35639510-4EEB3577-E212-482F-B085-35BDCC88F857 Q36016556-5B16DC02-50D7-4901-AF3F-C4FF5BC3B9F2 Q36132055-9FFAC27B-BDE1-43C3-8F39-E67D47518DC4 Q36134390-DB37714D-CAA8-48DB-91AE-2BBA573F0A48 Q36287892-CC4D9F5A-88DB-4719-A007-1A4518D74C1B Q36327934-3EC242E1-2BF1-4180-BE13-E301605AACC8 Q36328060-0653EED0-4591-4E46-99FF-5FC3D8798128 Q36329913-72984EEF-E32C-4148-B9C6-070612821FB4 Q37020199-2C0F6E48-A237-44D4-8CC6-A0ACE3100204

P2860

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

http://www.wikidata.org/entity/Q46731864

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@en

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@nl

type

label

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@en

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@nl

prefLabel

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@en

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@nl

P1433

Q46731864-354F5CC7-A097-4697-B24D-9F53D2536425

P1476

Q46731864-F9CA1BEE-E55C-49AC-86B4-2B56A19A5F80

P2093

Q46731864-05035F98-B972-4FE1-96AB-F3DFE7EA26C3

Q46731864-14823679-D5A6-4427-9C79-D98AA613D771

Q46731864-82781555-1A4A-4651-BC03-0070352CE824

Q46731864-850274D7-D289-49D6-A7A0-6C3640713CB6

Q46731864-A88F2164-6AA2-4BBB-9A76-0B9585180ADE

Q46731864-C7912C2D-244E-42FB-80C7-F5FE456F2F81

P2860

Q46731864-0385FECA-22B0-4EB1-BDC1-A9D0EDCD9C9E

Q46731864-067E9AF0-71E4-468D-9291-054CB20ADA8D

Q46731864-11C165B2-DBE2-4DCD-B136-B5518C441824

Q46731864-25BBC6EB-8329-4889-BF8C-F6C4FAC8D60C

Q46731864-26461B85-F275-4E7B-AF31-6BEE447F0EFD

Q46731864-27296824-BF22-4760-91DC-B96FE7D77D4B

Q46731864-2EB9CD38-A84F-4B34-8F62-87BBD3C81C47

Q46731864-3B533B44-055A-41F9-817A-06B533080E15

Q46731864-4D7B047D-BE6E-477B-82C5-FEA1786ED475

Q46731864-57ADAE25-B6E1-4300-B30C-7264C0C9EAA2

P304

Q46731864-C6341BAB-563F-4FA0-8A35-CE258F1AE4C5

P31

Q46731864-AC3BD389-0E87-485D-95FC-5C1D185F637C

P356

Q46731864-2464F5E3-23AD-4494-801E-B9E4CF5D44B8

P407

Q46731864-A136F3B5-BB37-4F55-B339-4B7C0B49D441

P433

Q46731864-6AAC0452-FBF9-4010-9205-FA5348CAF225

P478

Q46731864-5477FC83-41BF-4CBB-A026-2F896B9D618D

P577

Q46731864-C38525D1-7985-4A6D-AC38-2A46E01E40F7

P5875

Q46731864-3EC9DC60-E328-4534-B9C1-61D192073E35

P698

Q46731864-C94B855F-0522-4FB1-BC82-A847BAA9C47E

P921

Q46731864-38920873-FDCC-478D-90B7-539880ED08DD

Q46731864-93CDBF12-262F-4E87-942F-E26AEB430572

Q46731864-E03724E0-C087-4225-B755-CB9FF86B02AE

Q46731864-EE3128EE-1FF4-4E49-949F-B71DCC33845B

Q46731864-F5E20283-C0C8-4976-847A-41B26B93F8DA

P356

P1433

Human Reproduction

P1476

Combined lifestyle modificatio ...... ouble-blind multicentre study.

@en

P2093

Adam H Balen

http://www.w3.org/2001/XMLSchema#string

Catherine J Hayden

http://www.w3.org/2001/XMLSchema#string

Davinia White

http://www.w3.org/2001/XMLSchema#string

Julian H Barth

http://www.w3.org/2001/XMLSchema#string

Julie Glanville

http://www.w3.org/2001/XMLSchema#string

Thomas Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Fat and female fecundity: prospective study of effect of body fat distribution on conception rates

Treatment of obesity: need to focus on high risk abdominally obese patients.

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women.

Polycystic ovary syndrome and fat distribution: the central issue?

The role of lifestyle modification in polycystic ovary syndrome.

What is polycystic ovary syndrome? Are national views important?

P304

80-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEI311

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7566570

http://www.w3.org/2001/XMLSchema#string

P698

16199429

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome